Analysis of the significantly different metabolomic features. by Bhuripit Saraphol (20855573)

Subjects:

Mean values and 95% confidence intervals for recovery time, Average NN Interval (AVNN); Standard Deviation of NN Intervals (SDNN), Low Frequency/ High Frequency Ratio (LF/HF); and... by Robert Trybulski (10998702)

Subjects:

Summary of Biomarker Expression in Benign Samples. The STT and LTT groups exhibit significant changes in biomarker expression compared to the nontreatment group, measured on a two-... by Jinho Lee (587173)

Subjects:

The top 10 putative metabolites with the largest negative fold change between normal and thin cows. by Bhuripit Saraphol (20855573)

Subjects:

The top 10 putative metabolites with the largest positive fold change between normal and thin cows. by Bhuripit Saraphol (20855573)

Subjects:

Transepithelial resistance of NHBE decreases significantly after PAA exposure. by Ellie S. Burns (21246537)

Cloning of <i>DpAP2</i> promoter. by Lingru Ruan (18995544)

Subjects:

Fig 5 - by Lingru Ruan (18995544)

Subjects:

Growth of transgenic <i>D</i>. <i>parva</i> and control after one month. by Lingru Ruan (18995544)

Subjects:

Predicted <i>cis</i>-acting elements in <i>DpAP2</i> promoter. by Lingru Ruan (18995544)

Subjects:

Contents of chlorophyll a, chlorophyll b (Chl a, Chl b) and carotenoid in <i>D</i>. <i>parva</i> cells under treatment of various concentrations of MeJA and GA3. by Lingru Ruan (18995544)

Subjects:

Fig 2 - by Lingru Ruan (18995544)

Subjects:

Sequence of <i>DpAP2</i> promoter. by Lingru Ruan (18995544)

Subjects:

Amplification of <i>DpAP2</i> full-length cDNA. by Lingru Ruan (18995544)

Subjects:

Verification of transgenic <i>D</i>. <i>parva</i>. by Lingru Ruan (18995544)

Subjects:

Construction of transgenic <i>D</i>. <i>parva</i> overexpressing <i>DpAP2</i> gene. by Lingru Ruan (18995544)

Subjects:

Fig 4 - by Lingru Ruan (18995544)

Subjects:

Carotenoid contents of control and transgenic <i>D</i>. <i>parva</i>. by Lingru Ruan (18995544)

Subjects:

Phosphorylation as an Effective Tool to Improve Stability and Reduce Toxicity of Antimicrobial Peptides by Zufang Ba (11036420)

“…Among them, W₃BipY₈-P stood out as the most promising peptide, exhibiting similar antibacterial activity as its unphosphorylated analog W₃BipY₈ but with significantly reduced hemolytic activity (19-fold decrease), cytotoxicity (3.3-fold decrease), and an extended serum half-life 6.3 times longer than W₃BipY₈. …”

The higher the value, the stronger the correlation. by Xiaoxu Zhu (11764430)